A significant increase in T cell immunosenescence, as based on multiple markers (including naïve cell markers CD27/CD45RO, CD28, CD127 and CD57), is observed in type 2 diabetic patients with eGFR below 60 ml/min. This evidence concerns the gene B3GAT1 and type 2 diabetes mellitus.